Company intelligence / Profile preview
Inatherys
Évry-Courcouronnes, Île-de-France, Franceinatherys.com ↗
- Ownership
- Private
- Employees
- ~10
- Development stage
- Other
01
Overview
Inatherys has developed several monoclonal antibodies targeting cancer and inflammation. Their lead programs have demonstrated effectiveness in preclinical studies and are being prepared for clinical development in patients with advanced disease where traditional treatments have failed
- Therapeutic areas
- OncologyImmunology
- Modalities
- monoclonal antibodies (mAbs)antibody-drug conjugates (ADC)
- Industry
- Biotech
02
Drug pipeline
2 assets1 more asset in the full pipeline.
03
Partnerships
Partnership with Adult Hematology Department of Necker Hospital, Paris
Beyond the preview
Go deeper on Inatherys.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Inatherys.